numares is a fast-growing innovative diagnostics company that develops and markets software-based test systems for high throughput use in clinical diagnostics and life science research. The AXINON® System and its individual diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a “numaric” spectrum to evaluate metabolic networks. The output from these analyses provides physicians valuable information on the disease status of patients. numares developed its proprietary Magnetic Group Signaling (MGS®) technology to enable NMR for highly standardized and rapid throughput testing, forming a cost-effective new solution for real-time diagnostic purposes. The metabolic tests have the potential to address unmet medical needs in various field such as cardiovascular diseases, nephrology, oncology and neurology, shaping an important pillar in precision medicine. More information can be found at www.numares.com. For further information please contact: numares AG Dipl.-Biol. Christiane Proll, MBA Tel.: +49 941 2809 49-14 E-Mail: christiane.proll@numares.com
Looking for a particular numares AG employee's phone or email?
The numares AG annual revenue was $6.8 million in 2026.
Florian Voss is the CEO of numares AG.
19 people are employed at numares AG.
numares AG is based in Boston, Massachusetts.
The NAICS codes for numares AG are [62, 621].
The SIC codes for numares AG are [807, 80].